| Dr Brian Matthew Blair, MD | |
|
24900 Se Stark St Ste 103, Gresham, OR 97030 | |
| (503) 935-8088 | |
| Not Available |
| Full Name | Dr Brian Matthew Blair |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 11 Years |
| Location | 24900 Se Stark St Ste 103, Gresham, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770826372 | NPI | - | NPPES |
| 500760980 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD191957 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Mount Hood Medical Center | Gresham, OR | Hospital |
| Adventist Health Portland | Portland, OR | Hospital |
| Providence Portland Medical Center | Portland, OR | Hospital |
| Legacy Emanuel Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Clinic Pc | 2860390408 | 319 |
News Archive
Our tribute - and pledge - to Senator Kennedy is to continue working relentlessly on behalf of patients, many of whom saw him as their most dedicated champion and for whom medical innovation offers the greatest hope for restored health.
Obesity may cause a hyperactive immune system response to COVID-19 infection that makes it difficult to fight off the virus, according to a new manuscript published in the Endocrine Society's journal, Endocrinology.
Starting June 2013, the Porter Cancer Care Center at Porter Adventist Hospital becomes one of the few facilities in the country to offer highly advanced radiation therapy and radiosurgery cancer treatment options using the new Varian TrueBeam image-guided radiotherapy system.
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
› Verified 1 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
Our tribute - and pledge - to Senator Kennedy is to continue working relentlessly on behalf of patients, many of whom saw him as their most dedicated champion and for whom medical innovation offers the greatest hope for restored health.
Obesity may cause a hyperactive immune system response to COVID-19 infection that makes it difficult to fight off the virus, according to a new manuscript published in the Endocrine Society's journal, Endocrinology.
Starting June 2013, the Porter Cancer Care Center at Porter Adventist Hospital becomes one of the few facilities in the country to offer highly advanced radiation therapy and radiosurgery cancer treatment options using the new Varian TrueBeam image-guided radiotherapy system.
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
› Verified 1 days ago
| Entity Name | Oregon Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
Our tribute - and pledge - to Senator Kennedy is to continue working relentlessly on behalf of patients, many of whom saw him as their most dedicated champion and for whom medical innovation offers the greatest hope for restored health.
Obesity may cause a hyperactive immune system response to COVID-19 infection that makes it difficult to fight off the virus, according to a new manuscript published in the Endocrine Society's journal, Endocrinology.
Starting June 2013, the Porter Cancer Care Center at Porter Adventist Hospital becomes one of the few facilities in the country to offer highly advanced radiation therapy and radiosurgery cancer treatment options using the new Varian TrueBeam image-guided radiotherapy system.
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
› Verified 1 days ago
| Entity Name | Ts Billings Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497776488 PECOS PAC ID: 0143201954 Enrollment ID: O20040527000506 |
News Archive
Our tribute - and pledge - to Senator Kennedy is to continue working relentlessly on behalf of patients, many of whom saw him as their most dedicated champion and for whom medical innovation offers the greatest hope for restored health.
Obesity may cause a hyperactive immune system response to COVID-19 infection that makes it difficult to fight off the virus, according to a new manuscript published in the Endocrine Society's journal, Endocrinology.
Starting June 2013, the Porter Cancer Care Center at Porter Adventist Hospital becomes one of the few facilities in the country to offer highly advanced radiation therapy and radiosurgery cancer treatment options using the new Varian TrueBeam image-guided radiotherapy system.
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Matthew Blair, MD 541 Ne 20th Ave Ste 225, Portland, OR 97232-2895 Ph: (503) 963-2801 | Dr Brian Matthew Blair, MD 24900 Se Stark St Ste 103, Gresham, OR 97030 Ph: (503) 935-8088 |
News Archive
Our tribute - and pledge - to Senator Kennedy is to continue working relentlessly on behalf of patients, many of whom saw him as their most dedicated champion and for whom medical innovation offers the greatest hope for restored health.
Obesity may cause a hyperactive immune system response to COVID-19 infection that makes it difficult to fight off the virus, according to a new manuscript published in the Endocrine Society's journal, Endocrinology.
Starting June 2013, the Porter Cancer Care Center at Porter Adventist Hospital becomes one of the few facilities in the country to offer highly advanced radiation therapy and radiosurgery cancer treatment options using the new Varian TrueBeam image-guided radiotherapy system.
The Enterprise Center at Salem State College today announced that three companies have been named as finalists in the North of Boston Business Plan competition. The finalists include companies that provide online local advertising, environmentally responsible household products and a solar energy business.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
› Verified 1 days ago
Dr. Audry Kang, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 24900 Se Stark St Ste 103, Gresham, OR 97030 Phone: 503-935-8088 Fax: 503-935-8082 | |
Kent C Toland, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 24076 Se Stark St Ste 310, Gresham, OR 97030 Phone: 503-492-6510 | |
Dr. Melanie Ann Crites-bachert, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 24076 Se Stark St, Suite 310, Gresham, OR 97030 Phone: 503-492-6510 Fax: 503-492-6502 | |
Dr. Shammai Rockove, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 24076 Se Stark St, Suite 310, Gresham, OR 97030 Phone: 503-492-6510 Fax: 503-492-6502 | |
Dr. Robert L Kalez, MD PC Urology Medicare: Not Enrolled in Medicare Practice Location: 24900 Se Stark St Ste 208, Gresham, OR 97030 Phone: 503-666-3030 Fax: 503-666-3434 |